This symposium will address novel strategies for the treatment of hemophilia and thrombosis in children. The first part of the symposium will include discussions on new products including novel coagulation factor therapy for hemophilia and novel anticoagulants for thrombosis. The second part will look at new therapeutic approaches including gene therapy for hemophilia and an update on the use of thrombolysis in children with thrombosis.